Raymond James initiates coverage on Thor Industries (NYSE:THO) with a Underperform rating.
Evaxion Biotech Q2 EPS $(0.36) Down From $(0.24) YoY
Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.36) per share. This is a 50 percent decrease over losses of $(0.24) per share from the same period last year.